1. 2017 Biomedical HIV Prevention Forum
The 2017 Biomedical HIV Prevention Forum (BHPF), held on the 3rd of December as a pre-conference of ICASA was a key moment for WACI Health. Together with the New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) and Society for AIDS in Africa (SAA), WACI Health played a convening role with financial and technical support from many partners including: AVAC, International HIV/AIDS Alliance, International Partnership for Microbicides (IPM), HIV Prevention Trials Network (HPTN), AIDS Healthcare Foundation (AHF) and Alliance Cote d’Ivoire.
The BHPF forum brought together 190 participants including: researchers, HIV Prevention Research Advocates, communities, policy makers and development partners.
Focus of the BHPF is on promoting synergy between HIV prevention science and program, maximizing the impact of HIV prevention on incidence, access to care and health equity. Accelerating the diffusion of best and promising HIV prevention practices, policies and research and also forging new connections across the full range of HIV prevention and care providers, researchers, policy makers, advocates, and people living with and affected by HIV.
The forum featured four sessions with 15 speakers. Topics discussed ranged from population specific discussions (adolescents, women, key populations) to updates on biomedical HIV prevention research, PrEP access, combination prevention and sexual and, reproductive health and rights.